Risk factors for vascular events during lung cancer chemotherapy

K. Murata, M. Takamori, A. Wada, A. Fujita (Japan)

Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Session: Best supportive care and palliation for lung cancer patients
Session type: Thematic Poster Session
Number: 3311
Disease area: Pulmonary vascular diseases, Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Murata, M. Takamori, A. Wada, A. Fujita (Japan). Risk factors for vascular events during lung cancer chemotherapy. Eur Respir J 2010; 36: Suppl. 54, 3311

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors for cardiac complications after lung cancer surgery
Source: Eur Respir J 2004; 24: Suppl. 48, 172s
Year: 2004

Risk factors for early mortality in lung cancer
Source: Annual Congress 2012 - Epidemiology and care research of lung cancer
Year: 2012


Risk factors for lung cancer worldwide
Source: Eur Respir J 2016; 48: 889-902
Year: 2016




Risk factors for lung cancer in COPD
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017


Characteristics/biomarker risk factors in COPD/lung cancer
Source: Annual Congress 2009 - Nursing challenges at home and in hospital
Year: 2009


Factors associated with regional occurance of lung cancer
Source: Annual Congress 2010 - Epidemiology of lung cancer
Year: 2010

Venous thromboembolic disease in patients with small cell lung cancer: incidence and clinicopathological risk factors
Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Year: 2020


Interstital lung disease rates and risk factors in a UK lung cancer screening trial
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018



Clinical factors of long-term survival in patients with advanced lung cancer
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017

Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016

Women lung cancer: factors related to survival
Source: Eur Respir J 2006; 28: Suppl. 50, 84s
Year: 2006

Prognostic factors affecting survival in advanced non-small cell lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 75s
Year: 2004

Risk factors and prognosis of non-solid nodules in a lung cancer screening program
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019


Comorbidities in lung cancer progression
Source: International Congress 2017 – ME12 Comorbidities in lung cancer progression
Year: 2017

Analyses of prognostic factors in patients undergoing surgery for lung cancer.
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019


Prognostic factors in patients with lung cancer and brain metastases at presentation
Source: Eur Respir J 2007; 30: Suppl. 51, 670s
Year: 2007

Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018


Effects of prognostic factors on survival of the patients of non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 326s
Year: 2005

Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer
Source: Eur Respir J, 51 (5) 1702431; 10.1183/13993003.02431-2017
Year: 2018